New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 8, 2014
07:14 EDTSNTASynta Pharmaceuticals reports Q1 EPS 28c, consensus 29c
The company said, "There were no revenues recognized in 1Q14 and 1Q13. Research and development expenses were $17.6M for Q1." Reports Q1 General and administrative expenses $5.3M. Q1 revenue consensus $450K.
News For SNTA From The Last 14 Days
Check below for free stories on SNTA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 11, 2014
16:00 EDTSNTASynta Pharmaceuticals CEO hire a positive, says Jefferies
Subscribe for More Information
August 6, 2014
07:14 EDTSNTASynta Pharmaceuticals reports Q2 EPS (24c), consensus (27c)
Subscribe for More Information
07:02 EDTSNTASynta Pharmaceuticals names Anne Whitaker as CEO, effective September 2
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use